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PROSPECTIVE RANDOMIZED STUDY COMPARING
MONOPOLAR WITH BIPOLAR TRANSURETHRAL
RESECTION OF PROSTATE ON A LARGE COHORT OF
PATIENTS WITH BENIGN PROSTATIC OBSTRUCTION:
LONG TERM OUTCOMESGiovanni Palleschi*, Antonio Luigi Pastore, Yazan Al Salhi,
Andrea Fuschi, Gennaro Velotti, Antonino Leto, Antonio Carbone,
Latina, Italy
INTRODUCTION AND OBJECTIVES: Monopolar transurethral
resection of the prostate (TURP) is the gold standard surgical treatment
for bothersome moderate to severe lower urinary tract symptoms
(LUTS) secondary to benign prostate obstruction with enlarged pros-
tates. The aim of the study is to compare monopolar vs. bipolar TURP
focusing on operative and functional outcomes with a long term
follow-up.
METHODS: From January 2007 to July 2013 a total of 379
patients were randomized and prospectively scheduled to undergo bi-
polar (202) or monopolar (177) TURP. International prostate symptom
score (IPSS), IPSS-Quality of life (QoL), post-void residual and
maximum flow rate were assessed preoperatively and postoperatively
at 3, 12, 24 and 36 months. Operative time, length of catheterization
and length of hospitalization were all recorded. Rates of urethral stric-
tures and bladder neck contractures were also reported.
RESULTS: Perioperative results showed no statistical signifi-
cance between the two groups in terms of catheterization days, post-
void residual, IPSS, IPSS-QoL score, blood transfusion and TUR syn-
drome. The operative time was proved to be statistically significant in
the monopolar group while the hospitalization days was found statisti-
cally significant in the bipolar group. The 3, 12, 24 and 36 months follow
up showed significant and equal improvements in LUTS related to BPO
in the 2 treatment groups.
CONCLUSIONS: Monopolar and bipolar TURP are safe and
effective techniques for BPH. The 2 significant differences between
them were operative time in favour of the monopolar group and hos-
pitalization days in favour of the bipolar group. Bipolar TURP has the
principle advantage in preventing TUR syndrome that was reported in 2
monopolar TURP patients.
Source of Funding: NonePD23-04
THULIUM LASER ENUCLEATION (THULEP) VERSUS
TRANSURETHRAL RESECTION OF THE PROSTATE IN
SALINE (TURIS): A RANDOMIZED PROSPECTIVE TRIAL TO
COMPARE COSTS PER PROCEDUREGiorgio Bozzini*, Castellanza, Italy; Stefano Casellato,
Serena Maruccia, Monza, Italy; giovanni saredi, varese, Italy;
paolo parma, mantova, Italy; Gianluigi Taverna, Castellanza, Italy
INTRODUCTION AND OBJECTIVES: To compare the costs
per procedure between thulium laser transurethral enucleation of the
prostate (ThuLEP) and transurethral bipolar resection of the prostate
(TURIS) for treating benign prostatic hyperplasia (BPH) in a prospective
randomized trial.
METHODS: The study randomized 208 consecutive patients
with BPH to ThuLEP (n ¼ 102) or TURIS (n ¼106). For all patients were
evaluated preoperatively with regards to blood loss, catheterization
time, irrigation volume, hospital stay and operative time. At 3 months
after surgery they were also evaluated by International Prostate
Symptom Score (IPSS), maximum flow rate (Qmax), and postvoid re-
sidual urine volume (PVR) to see if a cost reduction could be correlated
with a worst outcome.
RESULTS: The patients in each study arm each showed no
significant difference in preoperative parameters. Compared with
TURIS, ThuLEP had same operative time (53.6931.44 vs
61.6618.70 minutes, P ¼ .123) but resulted in less hemoglobin
decrease (0.45 vs 2.83 g/dL, P ¼ .005). ThuLEP also needed less
catheterization time (1.3 vs 4.8 days, P ¼ .011), irrigation volume (29.4
vs 69.2 L, P ¼ .002), and hospital stay (1.7 vs 5.2 days, P ¼ .016).
Average cost for a ThuLEP was 1181 euros while was 1761,16 for a
TURIS (p< .005). During the 3 months of follow-up, the procedures did
not demonstrate a significant difference in Qmax, IPSS, PVR,
and QOLS.
CONCLUSIONS: ThuLEP and TURIS both relieve lower urinary
tract symptoms equally, with high efficacy and safety. ThuLEP was
statistically superior to TURIS as a cheaper procedure. However, pro-
cedures did not differ significantly in Qmax, IPSS, PVR, and QOLS
through 3 months of follow-up.
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INFERIOR TISSUE ABLATION AFTER 120W GREENLIGHT
LASER VAPORIZATION DOES NOT TRANSLATE INTO
INFERIOR CLINICAL OUTCOME COMPARED
CONVENTIONAL TURP: 3-YEAR RESULTS OF A
PROSPECTIVE 3D ULTRASOUND VOLUMETRY STUDYBenedikt Kranzbühler*, Oliver Gross, Christian D. Fankhauser,
Marian S. Wettstein, Nico C. Grossmann, Etienne X. Keller,
Daniel Eberli, Tullio Sulser, Cédric Poyet, Thomas Hermanns, Zurich,
Switzerland
INTRODUCTION AND OBJECTIVES: Functional short-term
outcome following 120W greenlight laser vaporization (LV) has been
shown to be comparable to conventional transurethral resection of the
prostate (TURP). However, mid-term results following 80W greenlight
LV revealed that high retreatment rates are common after the procedure
most likely due to insufficient tissue ablation. Short-term outcome of our
3D ultrasound volumetry study revealed a significantly lower volume
reduction one year after 120W LV compared to TURP. Additional follow-
up was now performed to investigate further changes in volume
reduction and associated clinical outcome 3 years after LV and TURP.
METHODS: A total of 174 patients (120W LV; n¼98, 56% vs.
TURP; n¼76, 44%) were included in this prospective study and were
followed for 3 years. Transrectal 3D ultrasound and planimetric volu-
metry of the prostate was performed preoperatively, after catheter
removal, 6W, 6M, 12M and 3Y. Clinical outcome parameters (PSA,
